165 related articles for article (PubMed ID: 10714604)
1. N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats).
Thanou M; Florea BI; Langemeÿer MW; Verhoef JC; Junginger HE
Pharm Res; 2000 Jan; 17(1):27-31. PubMed ID: 10714604
[TBL] [Abstract][Full Text] [Related]
2. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Luessen HL; de Leeuw BJ; de Boer BG; Verhoef JC; Junginger HE
Pharm Res; 1997 Sep; 14(9):1197-202. PubMed ID: 9327448
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE
J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647
[TBL] [Abstract][Full Text] [Related]
4. Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo.
Thanou M; Verhoef JC; Marbach P; Junginger HE
J Pharm Sci; 2000 Jul; 89(7):951-7. PubMed ID: 10861597
[TBL] [Abstract][Full Text] [Related]
5. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo.
Luessen HL; de Leeuw BJ; Langemeÿer MW; de Boer AB; Verhoef JC; Junginger HE
Pharm Res; 1996 Nov; 13(11):1668-72. PubMed ID: 8956332
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).
Kotzé AF; Luessen HL; de Leeuw BJ; de Boer AG; Verhoef JC; Junginger HE
J Control Release; 1998 Jan; 51(1):35-46. PubMed ID: 9685902
[TBL] [Abstract][Full Text] [Related]
7. Effects of N-trimethyl chitosan chloride, a novel absorption enhancer, on caco-2 intestinal epithelia and the ciliary beat frequency of chicken embryo trachea.
Thanou MM; Verhoef JC; Romeijn SG; Nagelkerke JF; Merkus FW; Junginger HE
Int J Pharm; 1999 Aug; 185(1):73-82. PubMed ID: 10425367
[TBL] [Abstract][Full Text] [Related]
8. Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo.
Thanou M; Nihot MT; Jansen M; Verhoef JC; Junginger HE
J Pharm Sci; 2001 Jan; 90(1):38-46. PubMed ID: 11064377
[TBL] [Abstract][Full Text] [Related]
9. Chitosan and its derivatives as intestinal absorption enhancers.
Thanou M; Verhoef JC; Junginger HE
Adv Drug Deliv Rev; 2001 Oct; 50 Suppl 1():S91-101. PubMed ID: 11576697
[TBL] [Abstract][Full Text] [Related]
10. Intestinal paracellular permeation enhancement with quaternised chitosan: in situ and in vitro evaluation.
Jonker C; Hamman JH; Kotzé AF
Int J Pharm; 2002 May; 238(1-2):205-13. PubMed ID: 11996824
[TBL] [Abstract][Full Text] [Related]
11. N-trimethyl chitosan chloride: optimum degree of quaternization for drug absorption enhancement across epithelial cells.
Hamman JH; Schultz CM; Kotzé AF
Drug Dev Ind Pharm; 2003 Feb; 29(2):161-72. PubMed ID: 12648013
[TBL] [Abstract][Full Text] [Related]
12. Effect of the degree of quaternization of N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).
Kotzé AF; Thanou MM; Luessen HL; de Boer BG; Verhoef JC; Junginger HE
Eur J Pharm Biopharm; 1999 May; 47(3):269-74. PubMed ID: 10382111
[TBL] [Abstract][Full Text] [Related]
13. Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs.
Thanou M; Verhoef JC; Verheijden JH; Junginger HE
Pharm Res; 2001 Jun; 18(6):823-8. PubMed ID: 11474787
[TBL] [Abstract][Full Text] [Related]
14. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
[TBL] [Abstract][Full Text] [Related]
15. Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers.
Thanou MM; Kotzé AF; Scharringhausen T; Luessen HL; de Boer AG; Verhoef JC; Junginger HE
J Control Release; 2000 Feb; 64(1-3):15-25. PubMed ID: 10640642
[TBL] [Abstract][Full Text] [Related]
16. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
[TBL] [Abstract][Full Text] [Related]
17. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
18. Effects of various absorption enhancers on transport of clodronate through Caco-2 cells.
Raiman J; Törmälehto S; Yritys K; Junginger HE; Mönkkönen J
Int J Pharm; 2003 Aug; 261(1-2):129-36. PubMed ID: 12878401
[TBL] [Abstract][Full Text] [Related]
19. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
20. Oral drug absorption enhancement by chitosan and its derivatives.
Thanou M; Verhoef JC; Junginger HE
Adv Drug Deliv Rev; 2001 Nov; 52(2):117-26. PubMed ID: 11718935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
